Stay updated on NSCLC Progressed Anti-PD-1 Clinical Trial
Sign up to get notified when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.

Latest updates to the NSCLC Progressed Anti-PD-1 Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov page no longer displays the HUDSON lung cancer trial record and instead shows a 403 Forbidden error.SummaryDifference23%

- Check11 days agoChange DetectedThe HUDSON Phase II lung cancer trial record is available with its study design, participant criteria, outcomes, results, and supporting documents. It replaces the previously displayed access-denied error page.SummaryDifference100%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe study page now shows a 403 Forbidden error, indicating the study record is blocked from access. The previous detailed content and associated documents are not accessible, with a standard error page displayed instead.SummaryDifference23%

- Check53 days agoChange DetectedThe page adds NIH grant/contract year annotations (2017 and 2023) and updates the revision from v3.6.5 to v3.6.6, reflecting administrative metadata rather than study content. These changes do not modify trial details, eligibility, or results.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page shows a new revision label (v3.6.5) indicating an updated version of the page, representing a minor update to the page structure or metadata rather than substantive content changes.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, signaling a minor maintenance update to the page. No study content or data appear to be modified.SummaryDifference0.0%

Stay in the know with updates to NSCLC Progressed Anti-PD-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.